Pfizer Inc. v. Lupin Ltd
1:13-cv-01153
Overview
Parties
Defendant
Lupin Ltd. Operating Company
Represented By
5 Attorneys ListedPhillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Phillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Plaintiff
UCB Pharma GmbH NPE (Individual / Inventor)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Pfizer Inc. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 6,858,650 Asserted | Asserted Patent | View Official Patent → |
| π©πͺ Germany | DE 19955190 A | Germany Counterpart | View Official Patent → |
| π PCT International (WIPO) | WO 2001035957 A1 | PCT World Application | View Official Patent → |
Amerigen Pharmaceuticals Limited et al. v. UCB Pharma GmbH
Alembic Pharmaceuticals Limited v. UCB Pharma GmbH
Torrent Pharmaceuticals Limited et al. v. UCB Pharma GmbH
Mylan Pharmaceuticals Inc. et al. v. UCB Pharma GmbH
Mylan Pharmaceuticals Inc. et al. v. UCB Pharma GmbH
Mylan Pharmaceuticals Inc. et al. v. UCB Pharma GmbH
Mylan Pharmaceuticals Inc. et al. v. UCB Pharma GmbH
Mylan Pharmaceuticals Inc et al. v. UCB Pharma GmbH
Pfizer Inc. v. Torrent Pharmaceuticals Limited
Pfizer Inc. v. Dr. Reddy's Laboratories Ltd.
Pfizer Inc. v. Accord Healthcare Inc.USA
Pfizer Inc. v. Amerigen Pharmaceuticals Inc.
Pfizer Inc. v. Amneal Pharmaceuticals LLC
Patents Involved
There are 5 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6858650
Stable salts of novel derivatives of 3,3-diphenylpropylamines
|
Filed: 2000-11-15
Issued: 2005-02-22
|
Expired (Term Ended)
+1149d PTA
Expires: 2024-01-08
|
|
|
US7384980
Derivatives of 3,3-diphenylpropylamines
|
Filed: 2005-08-10
Issued: 2008-06-10
|
Expired (Term Ended)
Expires: 2019-10-14
|
|
|
US7855230
Derivatives of 3,3-diphenylpropylamines
|
Filed: 2008-04-17
Issued: 2010-12-21
|
Expired (Term Ended)
Expires: 2019-08-17
|
|
|
US7985772
Derivatives of 3,3-diphenylpropylamines
|
Filed: 2010-06-14
Issued: 2011-07-26
|
Active (3.6 yrs remaining)
Expires: 2030-06-14
|
|
|
US8338478
Derivatives of 3,3-diphenylpropylamines
|
Filed: 2011-06-15
Issued: 2012-12-25
|
Active (4.6 yrs remaining)
Expires: 2031-06-15
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
High PTA (+1149 days) / Cellect Scrutiny β Over 1149 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
3
Dispositive
0
Granted
0
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings